These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 29716997)

  • 21. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
    Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
    Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
    Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
    Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease.
    Zhou JX; Li LX; Zhang H; Agborbesong E; Harris PC; Calvet JP; Li X
    Kidney Int; 2024 Aug; 106(2):258-272. PubMed ID: 38782200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.
    Zafar I; Ravichandran K; Belibi FA; Doctor RB; Edelstein CL
    Kidney Int; 2010 Oct; 78(8):754-61. PubMed ID: 20686448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
    Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
    FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
    Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nedd9 restrains renal cystogenesis in Pkd1-/- mice.
    Nikonova AS; Plotnikova OV; Serzhanova V; Efimov A; Bogush I; Cai KQ; Hensley HH; Egleston BL; Klein-Szanto A; Seeger-Nukpezah T; Golemis EA
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12859-64. PubMed ID: 25139996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
    Jin J; Gong J; Zhao L; Li Y; He Q
    Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.
    Ravichandran K; Zafar I; He Z; Doctor RB; Moldovan R; Mullick AE; Edelstein CL
    Hum Mol Genet; 2014 Sep; 23(18):4919-31. PubMed ID: 24847003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
    Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
    J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
    Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.
    Kipp KR; Rezaei M; Lin L; Dewey EC; Weimbs T
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F726-F731. PubMed ID: 26764208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.
    Distefano G; Boca M; Rowe I; Wodarczyk C; Ma L; Piontek KB; Germino GG; Pandolfi PP; Boletta A
    Mol Cell Biol; 2009 May; 29(9):2359-71. PubMed ID: 19255143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
    Hopp K; Kleczko EK; Gitomer BY; Chonchol M; Klawitter J; Christians U; Klawitter J
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F258-F267. PubMed ID: 35037466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models.
    Zhang X; Li LX; Ding H; Torres VE; Yu C; Li X
    J Am Soc Nephrol; 2021 Nov; 32(11):2759-2776. PubMed ID: 34716241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.
    Mekahli D; Decuypere JP; Sammels E; Welkenhuyzen K; Schoeber J; Audrezet MP; Corvelyn A; Dechênes G; Ong AC; Wilmer MJ; van den Heuvel L; Bultynck G; Parys JB; Missiaen L; Levtchenko E; De Smedt H
    Pflugers Arch; 2014 Aug; 466(8):1591-604. PubMed ID: 24193408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.
    Woo YM; Bae JB; Oh YH; Lee YG; Lee MJ; Park EY; Choi JK; Lee S; Shin Y; Lyu J; Jung HY; Lee YS; Hwang YH; Kim YJ; Park JH
    Hum Genet; 2014 Mar; 133(3):281-97. PubMed ID: 24129831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.